News

San Diego, CA, Nov. 06, 2023 (GLOBE NEWSWIRE) — Mindera Health today announces the signing a commercial agreement with Occum Health, LLC, a healthcare solutions company that is focused on delivering savings and improved benefits to self-insured employers. Through this agreement, Mindera’s proprietary psoriasis biologic prediction test, Mind.Px, is available to Occum Health’s more than […]

San Diego, CA, Oct 23, 2023 (GLOBE NEWSWIRE) — Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, announces that it has signed a provider contract with Contigo Health ConfigureNetTM provider network. This commercial agreement will make Mindera’s psoriasis biologic prediction test, Mind.Px, available to clients and their health plan members

Mindera Health, a precision medicine company developing personalized tools to optimize patient outcomes, today announced that additional patent protection has been issued in Australia for the core technology behind the dermal biomarker patch.   Australian patent number 2020239750 was issued August 3, 2023 and covers devices that can extract dermal biomarkers in situ. The inventors

Mindera Corp dba Mindera Health today announced that the General Services Administration (GSA) has awarded a 5-year contract to Mindera Health, enabling access to the Mind.Px™ test for patients with plaque psoriasis considering biologic therapy. San Diego, CA, Oct. 10, 2023 (GLOBE NEWSWIRE) — Mindera Health today announced that the General Services Administration (GSA) has

San Diego, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) — Mindera Health™ today announces the signing of a network provider contract with MediNcrease Health Plans, a national provider network and provider advocacy firm. This commercial agreement will make Mindera’s psoriasis biologic prediction test, Mind.Px™, available to the more than 15 million lives served by Clients and

HOUSTON, TX – SEPTEMBER 7, 2023 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today it has successfully secured new inpatient hospital ICD-10-PCS procedure codes applicable to its Aortix™ percutaneous mechanical circulatory support (pMCS) technology. The new codes represent a significant milestone as the

CRESTWOOD, KY, 5 July 2023: Liberate Medical, an emerging leader in the development of novel non-invasive neurostimulation devices focused on transforming respiratory care, announced today the successful closure of its $6.2M Series B financing round. The funding was co-led by a large strategic investor and Scientific Health Development, who will both join Liberate Medical’s Board,

Podimetrics, creator of the SmartMat™ and integrated clinical and patient support services that can help save the limbs and lives of people living with complex diabetes, today announced Barbara Greising will be joining the Podimetrics executive leadership team as Chief Commercial Officer. She will be tasked with ensuring more people — particularly those most at

Decompression Surgery with DST Stabilization May Be Viable Alternative to Transforaminal Lumbar Interbody Fusion (TLIF) for Degenerative Spondylolisthesis  San Carlos, Calif. (June 1, 2023) – A recently published paper in The Open Orthopaedics Journal compared outcomes for degenerative spondylolisthesis surgery using decompression and Empirical Spine’s LimiFlex™ Dynamic Sagittal Tether™ (DST) stabilization versus transforaminal lumbar interbody

Ron Rocca to Become Chief Executive Officer SAN DIEGO, CA – May 11, 2023 – Mindera Health™, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has announced a change in its executive leadership team. The company has announced industry veteran Ron Rocca will succeed George Mahaffey as President and Chief Executive